CONVATEC GROUP PLC
Convatec Group Plc is a public limited company registered in England and Wales under company number 10361298, with its registered office at 7th Floor, 20 Eastbourne Terrace, London W2 6LG. It was incorporated on 6 September 2016, initially under the name Convatec Group Limited before being re-registered as a public limited company on 10 October 2016, and its current status on the Companies House register is active.
The company is a global medical products and technologies business focused on the management of chronic conditions. Its principal activities are organised around four care categories: advanced wound care, ostomy care, continence care and infusion care, spanning wound dressings, stoma devices and accessories, continence catheters, and disposable infusion sets used with insulin pumps and other continuous-infusion therapies. Convatec traces its origins to 1978 as a division of E. R. Squibb & Sons and was restructured as Convatec Group Plc ahead of its 2016 stock market listing.
Convatec Group Plc has been listed on the London Stock Exchange under the ticker CTEC since its October 2016 initial public offering and has been a constituent of the FTSE 100 Index since December 2016. According to the company’s own press announcements, its global headquarters is located at its registered London address, following a relocation the company announced in 2023. The company has described its products and services as reaching customers in around 90 countries.
For the financial year ended 31 December 2025, Convatec Group Plc reported consolidated Group revenue of $2,439 million, an increase of 6.5% on a reported basis, and adjusted operating profit of $544 million, according to its FY2025 annual results announcement. These figures are reported on a consolidated basis for the group headed by Convatec Group Plc as the ultimate parent and listed reporting entity, rather than for the legal entity on a standalone basis.
Recent business developments include the 2022 acquisition of the US wound-care business Triad Life Sciences, a 2023 purchase of a nitric-oxide anti-infective technology platform from 30 Technology Ltd, and the 2022 suspension of sales operations in Russia and closure of manufacturing in Belarus following the invasion of Ukraine. During 2026 the company has continued an ongoing share buyback programme, with shares held in treasury reported to exceed 5% of total voting rights in August 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Convatec Group Plc is incorporated in England and Wales and has a premium listing on the London Stock Exchange, so its shareholder base is disclosed on a major-holdings basis rather than as a complete shareholder register. Under the UK’s Disclosure Guidance and Transparency Rules (DTR5), only holders whose voting rights cross defined notification thresholds (3% initially, then each further 1%) are required to notify the company and the market, so the holders identified below are the largest verified positions rather than a full list of shareholders.
Based on regulatory major-holdings notifications, BlackRock, Inc. held approximately 5.53% of total voting rights as of a notification dated 10 July 2026 (around 4.93% attached to shares and 0.60% held through financial instruments). FIL Limited, the Bermuda-registered Fidelity International investment vehicle, held approximately 5.06% of voting rights following a notification dated 27 May 2026, reported at approximately 5.02% in a subsequent notification around August 2026 as the company’s total voting rights base changed. Black Creek Investment Management Inc., a Toronto-based asset manager, has also filed repeated major-holdings notifications crossing the 5% threshold at various points since 2024; a current percentage was not located in this research, so it is noted here as a recurring notifiable holder rather than given a present-day figure. Separately, Convatec Group Plc has confirmed that shares held in its own treasury exceeded 5% of total voting rights during August 2026, reflecting an ongoing share buyback programme rather than a third-party shareholding.
An internally recorded shareholder listing associated with this profile, said to derive from a UK Confirmation Statement (CS01) filing, names different holders and percentages (including a single holding above 19%) that are materially inconsistent with the verified DTR5 notifications above and could not be corroborated against any primary source; it has not been used in this overview.
Ultimate beneficial ownership
No individual ultimate beneficial owner is identified for Convatec Group Plc. Companies House confirms that the company has been exempt from the requirement to maintain a PSC register since 5 September 2017 because its voting shares are admitted to trading on a UK regulated market, and every major shareholder identified through DTR5 notifications is an institutional asset manager rather than a natural person. No ownership chain is available that would allow a natural-person UBO to be identified or an effective ownership percentage to be calculated.
Data availability
Shareholder information for Convatec Group Plc is best classified as major shareholders only: verified regulatory notifications identify holders that have crossed the 3%/5% disclosure thresholds, but the complete register of all shareholders is not publicly available for a listed company of this kind. The information above reflects notifications filed through August 2026.
Sources
- Companies House — Persons with Significant Control, Convatec Group Plc (10361298), retrieved 11 September 2026 — https://find-and-update.company-information.service.gov.uk/company/10361298/persons-with-significant-control
- Investegate — FIL Limited, Holding(s) in Company, 27 May 2026 — https://www.investegate.co.uk/announcement/rns/convatec-group–ctec/holding-s-in-company/9590002
- Kalkine Media — FIL Limited surpasses 5% voting rights in Convatec Group plc, August 2026 — https://kalkinemedia.com/uk/news/announcements/fil-limited-surpasses-5-voting-rights-in-convatec-group-plc-ctec-as-of-august-2026
- Regulatory news summary — BlackRock, Inc., Holding(s) in Company, 10 July 2026 (via TipRanks company-announcements feed)
- EQS News — Black Creek Investment Management Inc., voting rights announcements, Convatec Group Plc — https://www.eqs-news.com/news/stimmrechtsanteile/black-creek-investment-management-inc-toronto-ontario-canada/5290d9cb-f92c-4fc4-bbd5-cc87cad9b916_en
- Investing.com — Convatec treasury shares exceed 5% of voting rights, August 2026
Registry feed — rows exactly as filed with Companies House, including entries the profile above does not cover.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| MFS SERIES TRUST I-MFS Research International Fund | 19.4% | Companies House | |
| Fidelity Investment Trust-Fidelity Diversified International Fund | 10.9% | Companies House | |
| NORTHERN LIGHTS FUND TRUST II-One Global ETF | 0% | Companies House | |
| Gamma Investing LLC | 0% | Companies House | |
| PNC Financial Services Group, Inc. | 0% | Companies House |
Officers
30
Companies House records ten active directors and one active company secretary for Convatec Group Plc as of this research (11 September 2026), together with a number of former directors and secretaries whose appointments have ended since the company’s 2016 incorporation. The current directors are Margaret Ewing, Tobias Hannes Hestler, Kimberly Sue Lody, Heather Lynn Mason, Jonathan Peter Mason, Brian Michael May, Dr John David Gibson McAdam, Sharon O’Keefe, Fiona Victoria Ryder and Jens Viebke; James Edward Spencer Kerton is the company secretary, appointed 7 May 2024. All current officers hold the single filed role of Director or Secretary. Officially disclosed nationalities on the register include British, American, Swiss and Swedish; these are the nationality values filed with Companies House and are not inferred from names, addresses or country of residence, which are recorded as separate fields.
Recent officer changes
- Jens Viebke appointed Director, effective 27 August 2026 (Companies House).
- Tobias Hannes Hestler appointed Director, effective 15 July 2026 (Companies House).
- Fiona Victoria Ryder appointed Director, effective 6 November 2025 (Companies House).
Data availability
Officer information for Convatec Group Plc is Full: Companies House publishes current and historical directors and secretaries for the company, including appointment dates, resignation dates where applicable, and an officially disclosed nationality field for each individual. Occupation, as distinct from legal role, was not separately verified in this research. Correspondence addresses shown on the register are service addresses for official communications only; they are not residential addresses and have not been used to infer nationality or country of residence.
Sources
- Companies House — Officers, Convatec Group Plc (10361298), retrieved 11 September 2026 — https://find-and-update.company-information.service.gov.uk/company/10361298/officers
Registry feed — rows exactly as filed with Companies House, including entries the profile above does not cover.
Group Structure
Convatec Group Plc is a publicly listed company and the ultimate parent of the Convatec group; it has no corporate parent of its own. It has been listed on the London Stock Exchange since its October 2016 IPO, its former private-equity owners, Nordic Capital and Avista Capital Partners, divested their remaining stake by May 2018, and Companies House records no registrable person or legal entity with significant control over it, consistent with the exemption that applies to companies whose shares trade on a UK regulated market.
Companies House filings independently verify a chain of UK subsidiaries beneath Convatec Group Plc. Convatec Group Holdings Limited (company number 12698069) is recorded as owned 75% or more (shares and voting rights) directly by Convatec Group Plc, a relationship notified on 25 June 2020. Convatec Group Holdings Limited in turn holds 75% or more of Convatec Holdings U.K. Limited (06622360), a relationship notified on 27 November 2020 — replacing Convatec Group Plc’s own earlier direct 75%-or-more holding in that company, which ceased on the same date, indicating an internal reorganisation that interposed Convatec Group Holdings Limited as a new intermediate holding company. Convatec Holdings U.K. Limited is separately recorded as holding 75% or more of Convatec Limited (01309639), the group’s principal UK trading entity.
Internal linkage data associated with this profile lists a much larger structure of direct and indirect subsidiaries spanning roughly 30 jurisdictions, including the United States, Denmark, Norway, the Netherlands, Switzerland, Spain, France, Germany, Japan, Singapore and others. The presence of Convatec Triad Life Sciences, LLC in that structure is consistent with Convatec’s confirmed 2022 acquisition of Triad Life Sciences. The wider international structure was spot-checked rather than verified entity-by-entity in this research, and ownership percentages for entities outside the UK chain described above were not independently confirmed.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| Convatec Group Plc | United Kingdom | 10361298 | Target company — ultimate parent, listed | N/A | Active | 11 Sep 2026 |
| Convatec Group Holdings Limited | United Kingdom | 12698069 | Direct subsidiary | 75% or more of shares and voting rights | Active | 25 Jun 2020 |
| Convatec Holdings U.K. Limited | United Kingdom | 06622360 | Indirect subsidiary (via Convatec Group Holdings Limited) | 75% or more of shares and voting rights | Active | 27 Nov 2020 |
| Convatec Limited | United Kingdom | 01309639 | Indirect subsidiary (via Convatec Holdings U.K. Limited) | 75% or more of shares and voting rights | Active | Retrieved 11 Sep 2026 |
Data availability
Corporate-linkage information for Convatec Group Plc is Partial: the immediate UK ownership chain down to Convatec Limited is independently verified through Companies House PSC filings, but the much larger multi-country subsidiary structure recorded internally for this profile has not been verified entity-by-entity and its current accuracy cannot be confirmed from this research.
Sources
- Companies House — Persons with Significant Control, Convatec Group Holdings Limited (12698069), retrieved 11 September 2026
- Companies House — Persons with Significant Control, Convatec Holdings U.K. Limited (06622360), retrieved 11 September 2026
- Companies House — Persons with Significant Control, Convatec Limited (01309639), retrieved 11 September 2026
- Wikipedia — Convatec, retrieved 11 September 2026 (company history, IPO and private-equity exit)
Registry feed — rows exactly as filed with Companies House, including entries the profile above does not cover.
CONVATEC GROUP PLC
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What does CONVATEC GROUP PLC do?
Convatec Group Plc is a UK-incorporated public limited company (company number 10361298, registered in England and Wales) and the ultimate parent of the global Convatec group. It develops and supplies medical technologies for chronic condition management, principally in four care categories: advanced wound care, ostomy care, continence care and infusion care, serving customers in around 90 countries.
Who owns CONVATEC GROUP PLC?
Convatec Group Plc's shareholder disclosure is major shareholders only, based on DTR5 regulatory notifications rather than a full register. Verified notifications show BlackRock, Inc. holding approximately 5.53% of voting rights (10 July 2026) and FIL Limited holding approximately 5.06% (27 May 2026), with Black Creek Investment Management Inc. having also filed repeated major-holdings notifications since 2024. The company's own treasury shareholding exceeded 5% of voting rights in August 2026.
Who is CONVATEC GROUP PLC's UBO (Ultimate Beneficial Owner)?
No individual Ultimate Beneficial Owner is identified for Convatec Group Plc. Companies House confirms the company is exempt from PSC disclosure because its shares are admitted to trading on a UK regulated market, and its disclosed major shareholders are institutional asset managers rather than natural persons.
What is CONVATEC GROUP PLC's company registration number?
CONVATEC GROUP PLC's registration number is 10361298, filed with Companies House in United Kingdom. Its current status on the register is active.
Is CONVATEC GROUP PLC still an active company?
CONVATEC GROUP PLC's status on Companies House is listed as active.
When was CONVATEC GROUP PLC incorporated?
CONVATEC GROUP PLC was incorporated on 6 September 2016, according to Companies House.
What is CONVATEC GROUP PLC's registered address?
The registered address on file for CONVATEC GROUP PLC is London, United Kingdom.
What legal structure is CONVATEC GROUP PLC registered as?
CONVATEC GROUP PLC is registered as a Public Limited Company in United Kingdom.
What is CONVATEC GROUP PLC's revenue?
For the financial year ended 31 December 2025, Convatec Group Plc reported consolidated Group revenue of $2,439 million, up 6.5% on a reported basis, with adjusted operating profit of $544 million, according to its FY2025 annual results announcement.
Is CONVATEC GROUP PLC listed on a stock exchange?
Convatec Group Plc has been listed on the London Stock Exchange under ticker CTEC since its October 2016 IPO and has been a constituent of the FTSE 100 Index since December 2016.
Who are the officers/directors of CONVATEC GROUP PLC?
Companies House records ten active directors and one active company secretary for Convatec Group Plc as of September 2026, including recent appointments of Jens Viebke (27 August 2026), Tobias Hannes Hestler (15 July 2026) and Fiona Victoria Ryder (6 November 2025), alongside a number of former officers whose appointments have ended since the company's 2016 incorporation.
Does CONVATEC GROUP PLC have a parent company or subsidiaries?
Convatec Group Plc is the ultimate parent of its group and has no corporate parent of its own. Companies House filings verify a direct subsidiary, Convatec Group Holdings Limited (75% or more owned, notified 25 June 2020), which in turn controls Convatec Holdings U.K. Limited and, further down the chain, Convatec Limited. Internal linkage data also lists a much larger international subsidiary structure spanning roughly 30 jurisdictions that was only partially spot-checked in this research.
Can Zavia monitor changes to CONVATEC GROUP PLC's ownership over time?
This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to CONVATEC GROUP PLC's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CONVATEC GROUP PLC's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like CONVATEC GROUP PLC's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Companies House and was last synced on 8 September 2026.